Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer

A. Avan; K. Quint; F. Nicolini; N. Funel; A.E. Frampton; M. Maftouh; S. Pelliccioni; G.J. Schuurhuis; G.J. Peters; E. Giovannetti

doi:https://doi.org/10.2174/138161213804547312

Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer

A. Avan, K. Quint, F. Nicolini, N. Funel, A.E. Frampton, M. Maftouh, S. Pelliccioni, G.J. Schuurhuis, G.J. Peters, E. Giovannetti

Research output: Contribution to journal › Article › Academic › peer-review

58 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	940-950
Journal	Current pharmaceutical design
Volume	19
Issue number	5
DOIs	https://doi.org/10.2174/138161213804547312
Publication status	Published - 2013

Access to Document

https://doi.org/10.2174/138161213804547312

Cite this

@article{08d883072e0c41ac99c00d11743b6417,

title = "Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer",

author = "A. Avan and K. Quint and F. Nicolini and N. Funel and A.E. Frampton and M. Maftouh and S. Pelliccioni and G.J. Schuurhuis and G.J. Peters and E. Giovannetti",

year = "2013",

doi = "https://doi.org/10.2174/138161213804547312",

language = "Undefined/Unknown",

volume = "19",

pages = "940--950",

journal = "Current Pharmaceutical Design",

issn = "1381-6128",

publisher = "Bentham Science Publishers B.V.",

number = "5",

}

TY - JOUR

T1 - Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer

AU - Avan, A.

AU - Quint, K.

AU - Nicolini, F.

AU - Funel, N.

AU - Frampton, A.E.

AU - Maftouh, M.

AU - Pelliccioni, S.

AU - Schuurhuis, G.J.

AU - Peters, G.J.

AU - Giovannetti, E.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.2174/138161213804547312

DO - https://doi.org/10.2174/138161213804547312

M3 - Article

SN - 1381-6128

VL - 19

SP - 940

EP - 950

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

IS - 5

ER -